Announcement on the Opening of Special Account for Fund-raising and Signing of Tripartite Custody Agreement for Special Account for Fund-raising Storage
Announcement regarding payment of outstanding taxes.
Announcement on voluntary disclosure of the completion of the first subject enrollment in the phase I clinical trial for GB08 injection.
Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Legal opinion from JiaYuan Law Firm, Peking regarding the second interim shareholder meeting in 2024 of Sinovac Biotech Co., Ltd.
2024 Second Interim Shareholder Meeting Documentation
Proposal from the second board of directors' audit committee to initiate the selection of audit agencies for the year 2024.
Announcement regarding the opening of a dedicated settlement account for wealth management products.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Jiayuan Law Firm on the 2023 Annual General Meeting of Shareholders of Kexing Biopharmaceutical Co., Ltd.
Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
2023 Annual General Meeting of Shareholders Meeting Materials
Notice on requesting the shareholders' meeting to authorize the board of directors to handle matters relating to issuing shares to specific targets through simple procedures
Notice on amending the “Articles of Association” and part of the governance system
Board of Directors Rules of Procedure
Rules of work of the Board of Directors Audit Committee
Rules of work of the Nomination Committee of the Board
Rules of work of the Board of Directors Remuneration and Assessment Committee
2024 “Improve Quality, Increase Efficiency, and Focus on Return” Special Action Plan
Special report of the board of directors on the self-inspection of the independence of independent directors
No Data